GO:2001237 negative regulation of extrinsic apoptotic signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001237 describes any process that stops, prevents or reduces the frequency, rate or extent of the extrinsic apoptotic signaling pathway, the death-receptor-driven route to programmed cell death.
• The extrinsic pathway is initiated when ligands such as TRAIL or FasL engage death receptors, leading to FADD recruitment, caspase-8 activation and executioner caspase activation.
• Negative regulators of this pathway include c-FLIP, Nogo-B (RTN4B), EMILIN2, DAPK1-modulating factors and multiple microRNAs that tune TRAIL sensitivity.
• Loss of negative regulation causes excessive apoptosis in degenerative and immune disorders, whereas gain of negative regulation promotes tumor survival and metastasis.
• Key experimental models include CRISPR knockout of c-FLIP (CFLAR), Nogo-B (RTN4B) or FADD, combined with TRAIL/FasL stimulation and caspase-3/7 readouts.
• The term is central to cancer biology, autoimmune lymphoproliferative syndromes and cryoablation-induced tissue injury research.
Description
The Gene Ontology term GO:2001237, negative regulation of extrinsic apoptotic signaling pathway, captures every cellular process that restrains death-receptor-mediated apoptosis. The extrinsic apoptotic signaling pathway is triggered when extracellular ligands such as TRAIL or FasL bind death receptors, causing receptor trimerization, FADD adaptor recruitment and caspase-8 activation, which in turn cleaves executioner caspases and commits the cell to death. Because this pathway is a primary mechanism of immune surveillance and tissue homeostasis, its negative regulation is essential to prevent inappropriate cell death and to allow survival signals to prevail in specific contexts. Research into GO:2001237 has revealed a diverse set of negative regulators, including the extracellular matrix glycoprotein EMILIN2, the reticulon family member Nogo-B (RTN4B), the caspase-8 homolog c-FLIP, and several microRNAs that dampen TRAIL signaling. These regulators act at different nodes: at the receptor level, at the DISC (death-inducing signaling complex), and downstream at caspase activation. Their dysfunction is linked to cancer progression, autoimmune lymphoproliferative syndromes and resistance to apoptosis-based therapies. For researchers, GO:2001237 provides a conceptual framework to interrogate how cells balance life and death decisions. Understanding which genes negatively regulate extrinsic apoptosis, and how, is critical for developing targeted interventions in oncology, immunology and regenerative medicine.
negative regulation of extrinsic apoptotic signaling pathway At A Glance
| GO ID | GO:2001237 |
|---|---|
| GO term | negative regulation of extrinsic apoptotic signaling pathway |
| Ontology | biological_process |
| Synonym | negative regulation of extrinsic apoptosis; negative regulation of extrinsic apoptotic signalling pathway |
| Major function | Suppression of death-receptor-mediated apoptosis to promote cell survival under specific physiological or pathological conditions |
| Related pathway | Extrinsic apoptotic signaling pathway (death receptor pathway) |
| Key regulators | c-FLIP (CFLAR), Nogo-B (RTN4B), EMILIN2, FADD, DAPK1, microRNAs |
| Disease relevance | Cancer metastasis, autoimmune lymphoproliferative syndromes, cryoablation-induced tissue injury |
What Is GO:2001237?
GO:2001237 is defined by QuickGO as any process that stops, prevents or reduces the frequency, rate or extent of the extrinsic apoptotic signaling pathway. In practical terms, it encompasses molecular events that inhibit death-receptor-induced apoptosis, such as sequestration of death ligands, blockade of FADD recruitment, inhibition of caspase-8 activation, or upregulation of anti-apoptotic proteins like c-FLIP.
Why Is negative regulation of extrinsic apoptotic signaling pathway Important in Cell Biology?
GO:2001237 is important because the extrinsic apoptotic pathway is a major mechanism by which the immune system eliminates infected, transformed or damaged cells, and its negative regulation determines whether a cell survives or dies in response to death ligands such as TRAIL and FasL. Dysregulation of this process contributes to cancer progression, autoimmune diseases and resistance to apoptosis-inducing therapies, making it a high-value target for both basic research and therapeutic development.
• Controls sensitivity to TRAIL and FasL, which are central to immune surveillance and cancer therapy.
• Loss of negative regulation can cause excessive apoptosis in degenerative and immune disorders.
• Gain of negative regulation promotes tumor cell survival and metastasis.
• c-FLIP and Nogo-B are established negative regulators with direct clinical relevance in colorectal cancer.
• EMILIN2 provides a matrix-derived mechanism to inhibit extrinsic apoptosis.
• MicroRNAs fine-tune TRAIL signaling and represent potential therapeutic targets.
• DAPK1 modulation by tissue factor/FVIIa illustrates coagulation-linked control of apoptosis.
• FADD is a key node whose regulation affects both apoptosis and necroptosis.
• Cryoablation-induced tissue injury involves apoptotic signaling across breast cancer subtypes.
• Autoimmune lymphoproliferative syndromes highlight the importance of proper apoptotic restraint.
What Happens During negative regulation of extrinsic apoptotic signaling pathway?
Receptor-level inhibition
In simple terms: Cells can block the first step of the death signal by preventing death ligands from activating their receptors.
Negative regulation at the receptor level includes mechanisms that reduce ligand availability, decoy receptor sequestration, or receptor internalization. For example, the extracellular matrix glycoprotein EMILIN2 negatively regulates the extrinsic apoptotic pathway, likely by interfering with death receptor activation. Tissue factor/FVIIa signaling prevents the extrinsic pathway by regulating DAPK1, a tumor suppressor involved in death receptor signaling.
DISC assembly blockade
In simple terms: After a death receptor is activated, it must recruit adaptor proteins to form a signaling platform; blocking this platform stops the death signal.
The death-inducing signaling complex (DISC) forms when FADD binds activated death receptors and recruits caspase-8. Negative regulators such as c-FLIP compete with caspase-8 for FADD binding, preventing caspase-8 activation and downstream apoptosis. Nogo-B (RTN4B) interacts with c-FLIP to inhibit the apoptotic pathway in colorectal cancer cells.
Caspase-8 and caspase-3/7 inhibition
In simple terms: Even if the DISC forms, cells can block the executioner caspases that carry out cell death.
Inhibitor of apoptosis proteins (IAPs) and other factors can directly or indirectly suppress caspase-8 and downstream executioner caspases. Negative regulation of extrinsic apoptosis often converges on preventing caspase-3 and caspase-7 activation, thereby halting the proteolytic cascade that dismantles the cell.
MicroRNA-mediated fine-tuning
In simple terms: Small RNA molecules can dial down the production of proteins needed for the death signal.
MicroRNAs regulate TRAIL-mediated signaling by targeting components of the extrinsic pathway, including death receptors, FADD, caspase-8 and c-FLIP. This layer of negative regulation allows cells to adjust their sensitivity to apoptosis in different cancer contexts.
Cross-talk with survival signaling
In simple terms: Survival pathways can actively suppress the death pathway, tipping the balance toward life.
Negative regulation of extrinsic apoptosis is integrated with survival signaling. For instance, tissue factor/FVIIa signaling modulates DAPK1 to prevent apoptosis, illustrating cross-talk between coagulation and cell death pathways. Similarly, EMILIN2 provides matrix-derived survival cues that inhibit extrinsic apoptosis.
Key Genes Involved in GO:2001237 negative regulation of extrinsic apoptotic signaling pathway
The following genes and proteins are experimentally implicated in the negative regulation of the extrinsic apoptotic signaling pathway, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CFLAR (c-FLIP) | Competes with caspase-8 for FADD binding, blocking DISC-mediated caspase activation | Knockout enhances TRAIL-induced apoptosis; target in colorectal cancer |
| RTN4B (Nogo-B) | Interacts with c-FLIP to inhibit extrinsic apoptosis | Knockdown sensitizes colorectal cancer cells to apoptosis |
| EMILIN2 | Extracellular matrix glycoprotein that negatively regulates extrinsic apoptosis | Modulates death receptor signaling; matrix-derived survival factor |
| FADD | Adaptor protein essential for DISC formation; its regulation affects apoptosis and necroptosis | Knockout abolishes extrinsic apoptosis; key node for pathway dissection |
| DAPK1 | Tumor suppressor involved in death receptor signaling; modulated by TF/FVIIa | Target of negative regulation by coagulation factors |
| TRAIL (TNFSF10) | Death ligand that triggers extrinsic apoptosis | Central to cancer therapy; sensitivity tuned by negative regulators |
| FASLG (FasL) | Death ligand that activates Fas receptor | Immune surveillance and autoimmune disease relevance |
| TNFRSF10A/B (DR4/DR5) | Death receptors for TRAIL | Receptor-level control of extrinsic apoptosis |
| CASP8 | Initiator caspase in extrinsic apoptosis | Downstream effector; inhibited by c-FLIP |
| CASP3 | Executioner caspase | Readout of apoptosis; inhibited by IAPs |
| BIRC2/3 (cIAP1/2) | Inhibitor of apoptosis proteins | Negative regulators of caspase activation |
| MIRs (e.g., miR-25, miR-221) | MicroRNAs targeting extrinsic pathway components | Fine-tune TRAIL sensitivity in cancers |
| TF (Tissue Factor) | Coagulation factor that prevents extrinsic apoptosis via DAPK1 | Links coagulation to cell survival |
| F7 (FVIIa) | Coagulation protease that modulates DAPK1 | Negative regulation of apoptosis |
| RIPK1 | Kinase involved in necroptosis and apoptosis cross-talk | Regulated by FADD-dependent complexes |
| RIPK3 | Kinase in necroptosis pathway | Cross-talk with extrinsic apoptosis |
| MLKL | Executioner of necroptosis | Downstream of RIPK3; relevant to FADD regulation |
| NFKB1 | Transcription factor promoting survival gene expression | Indirect negative regulation of apoptosis |
How Is negative regulation of extrinsic apoptotic signaling pathway Regulated?
Negative regulation of the extrinsic apoptotic signaling pathway is itself regulated at multiple levels. Transcription factors such as NF-kB induce anti-apoptotic proteins including c-FLIP and IAPs. MicroRNAs provide post-transcriptional control by targeting death receptors, FADD, caspase-8 and c-FLIP. Extracellular matrix components like EMILIN2 can modulate receptor activation. Coagulation factors such as tissue factor/FVIIa regulate DAPK1 to prevent apoptosis. These layers ensure that cell death is tightly controlled and context-dependent.
negative regulation of extrinsic apoptotic signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CFLAR (c-FLIP) | Colorectal cancer, TRAIL resistance | CRISPR knockout in HCT116 or SW480 cells |
| RTN4B (Nogo-B) | Colorectal cancer | Knockdown or knockout in colorectal cancer cell lines |
| EMILIN2 | Matrix-derived survival in cancer | Overexpression or knockout in breast cancer models |
| FADD | Autoimmune lymphoproliferative syndromes, necroptosis | Knockout in Jurkat or primary T cells |
| DAPK1 | Coagulation-linked apoptosis resistance | Point mutation or knockout in endothelial cells |
Cancer progression and metastasis
Negative regulation of extrinsic apoptosis promotes tumor cell survival and metastasis by conferring resistance to TRAIL and FasL-mediated killing. TRAIL/death receptor signaling is a key determinant of metastatic potential, and cancer cells often upregulate c-FLIP, Nogo-B or microRNAs that dampen the pathway. Understanding these mechanisms is critical for developing TRAIL-sensitizing therapies.
Autoimmune lymphoproliferative syndromes
Defects in apoptosis regulation, including impaired extrinsic pathway control, contribute to autoimmune lymphoproliferative syndromes. Immune checkpoint deficiencies can lead to lymphoproliferation and autoimmunity, highlighting the importance of proper negative regulation for immune homeostasis.
Cryoablation-induced tissue injury
Apoptotic signaling across breast cancer subtypes is modulated by cryoablation, a technique that induces tissue injury. Negative regulators of extrinsic apoptosis may influence the extent of cryoablation-induced cell death and subsequent immune responses.
Coagulation-linked cell survival
Tissue factor/FVIIa signaling prevents extrinsic apoptosis by regulating DAPK1, linking coagulation to cell survival. This has implications for thrombosis, cancer and inflammatory diseases where coagulation and apoptosis intersect.
From negative regulation of extrinsic apoptotic signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of c-FLIP sensitize cancer cells to TRAIL? | CFLAR knockout cell line + TRAIL treatment |
| Does Nogo-B interact with c-FLIP to inhibit apoptosis? | RTN4B knockout or knockdown + co-IP |
| How does EMILIN2 modulate death receptor signaling? | EMILIN2 overexpression or knockout in matrix-producing cells |
| What is the role of FADD in extrinsic apoptosis vs necroptosis? | FADD knockout with TNF-alpha and zVAD treatment |
| How do microRNAs regulate TRAIL sensitivity? | miRNA mimic/inhibitor transfection + TRAIL assay |
| Does TF/FVIIa prevent apoptosis via DAPK1? | DAPK1 point mutation or knockdown + TF/FVIIa stimulation |
How to Study the negative regulation of extrinsic apoptotic signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Caspase-3/7 activity assay | Executioner caspase activity | Quantify apoptosis after TRAIL/FasL treatment |
| Annexin V flow cytometry | Phosphatidylserine externalization | Detect early apoptosis in knockout cells |
| Co-immunoprecipitation | Protein-protein interactions | Study DISC assembly and c-FLIP binding |
| CRISPR knockout screening | Gene essentiality for apoptosis resistance | Identify novel negative regulators |
| RNA-seq | Transcriptional changes | Profile pathway rewiring after regulator loss |
| Proteomics | Protein expression and modifications | Map signaling changes in extrinsic apoptosis |
| MicroRNA mimic/inhibitor assays | miRNA-mediated regulation | Test TRAIL sensitivity modulation |
| TUNEL staining | DNA fragmentation | Confirm apoptosis in tissue sections |
Apoptosis assays
Caspase-3/7 activity assays, Annexin V staining and TUNEL are standard methods to measure extrinsic apoptosis. These readouts are used to quantify the effect of negative regulators such as c-FLIP or Nogo-B after TRAIL or FasL stimulation.
Co-immunoprecipitation and proximity ligation
Protein-protein interactions within the DISC, such as FADD-caspase-8 or c-FLIP-FADD, are studied by co-immunoprecipitation and proximity ligation assays. These methods reveal how negative regulators block complex assembly.
RNA interference and CRISPR screens
Loss-of-function screens using siRNA or CRISPR libraries identify negative regulators of extrinsic apoptosis. Such screens have uncovered microRNAs and proteins that modulate TRAIL sensitivity.
Transcriptomics and proteomics
RNA-seq and mass spectrometry-based proteomics profile changes in gene and protein expression upon modulation of negative regulators, providing systems-level insights into pathway rewiring.
How CRISPR Can Be Used to Study GO:2001237 negative regulation of extrinsic apoptotic signaling pathway
Knockout
CRISPR knockout of negative regulators such as CFLAR (c-FLIP) or RTN4B (Nogo-B) sensitizes cancer cells to TRAIL-induced apoptosis, providing causal evidence for their role in GO:2001237. Knockout of FADD abolishes extrinsic apoptosis and shifts cells toward necroptosis.
Point Mutation
Point mutations can dissect specific domains required for negative regulation, such as the death effector domains of c-FLIP or the interaction interface of Nogo-B with c-FLIP. DAPK1 point mutants can reveal how TF/FVIIa modulates its pro-apoptotic function.
Knock-in
Knock-in of tagged versions of c-FLIP, FADD or Nogo-B allows real-time tracking of DISC dynamics and protein interactions in live cells. This approach is valuable for understanding spatiotemporal control of extrinsic apoptosis.
Overexpression
Overexpression of EMILIN2 or c-FLIP confers resistance to extrinsic apoptosis, validating their negative regulatory function. Overexpression models are useful for testing whether a candidate gene is sufficient to block death receptor signaling.
How EDITGENE Supports negative regulation of extrinsic apoptotic signaling pathway Research
Researchers studying negative regulation of extrinsic apoptotic signaling pathway-related genes often need to determine whether a candidate gene is causally involved in restraining death receptor signaling. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of extrinsic apoptotic signaling pathway research.
Frequently Asked Questions About negative regulation of extrinsic apoptotic signaling pathway
What is GO:2001237?
GO:2001237 is the Gene Ontology term for negative regulation of extrinsic apoptotic signaling pathway, describing any process that stops, prevents or reduces death-receptor-mediated apoptosis.
What genes are involved in negative regulation of extrinsic apoptotic signaling pathway?
Key genes include CFLAR (c-FLIP), RTN4B (Nogo-B), EMILIN2, FADD, DAPK1 and various microRNAs.
How does c-FLIP inhibit extrinsic apoptosis?
c-FLIP competes with caspase-8 for binding to FADD at the DISC, preventing caspase-8 activation and downstream apoptosis.
What is the role of Nogo-B in apoptosis?
Nogo-B (RTN4B) interacts with c-FLIP to negatively regulate the apoptotic pathway in colorectal cancer cells.
How do microRNAs regulate TRAIL signaling?
MicroRNAs target components of the extrinsic pathway such as death receptors, FADD, caspase-8 and c-FLIP, tuning TRAIL sensitivity in cancers.
What diseases are linked to dysregulated extrinsic apoptosis?
Cancer metastasis, autoimmune lymphoproliferative syndromes and cryoablation-induced tissue injury are linked to dysregulated extrinsic apoptosis.
How can I study negative regulation of extrinsic apoptosis?
Use CRISPR knockout of candidate genes, followed by TRAIL or FasL stimulation and caspase-3/7 or Annexin V readouts.
What is the extrinsic apoptotic signaling pathway?
It is the death-receptor-initiated pathway where ligands like TRAIL or FasL activate caspase-8 via FADD, leading to apoptosis.
Does EMILIN2 affect apoptosis?
Yes, EMILIN2 is an extracellular matrix glycoprotein that negatively regulates the extrinsic apoptotic pathway.
What is the role of DAPK1 in extrinsic apoptosis?
DAPK1 is a tumor suppressor involved in death receptor signaling; tissue factor/FVIIa prevents apoptosis by regulating DAPK1.
Conclusion
GO:2001237, negative regulation of extrinsic apoptotic signaling pathway, is a critical biological process that governs cell survival decisions in response to death ligands. Its dysregulation underpins cancer progression, autoimmune disorders and tissue injury, making it a prime target for therapeutic intervention. By leveraging CRISPR-based models and functional assays, researchers can dissect the molecular players and translate these insights into clinical applications.
References
- 1. Mongiat M et al.. 2007. Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2.. Mol Cell Biol 27(20):7176-87 PMID: 17698584
- 2. Oh YT et al.. 2021. Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling.. Biomolecules 11(4) PMID: 33810241
- 3. Gámez-Díaz L et al.. 2021. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.. Biomed J 44(4):400-411 PMID: 34384744
- 4. Panfil A et al.. 2026. Apoptotic Signaling Across Breast Cancer Subtypes and Cryoablation-Induced Tissue Injury.. Int J Mol Sci 27(12) PMID: 42352901
- 5. Fayyaz S et al.. 2019. MicroRNA regulation of TRAIL mediated signaling in different cancers: Control of micro steering wheels during the journey from bench-top to the bedside.. Semin Cancer Biol 58:56-64 PMID: 30716480
- 6. Lee EW et al.. 2012. The roles of FADD in extrinsic apoptosis and necroptosis.. BMB Rep 45(9):496-508 PMID: 23010170
- 7. Kawaguchi N et al.. 2018. Nogo-B (Reticulon-4B) functions as a negative regulator of the apoptotic pathway through the interaction with c-FLIP in colorectal cancer cells.. Biochim Biophys Acta Mol Basis Dis 1864(8):2600-2609 PMID: 29684585
- 8. Aberg M et al.. 2011. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).. Thromb Res 127(2):141-8 PMID: 21168190
